The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
about
Innovative Therapeutics: Designer Natriuretic Peptides.Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediatorBiomarkers and cardiovascular risk assessment for primary prevention: an update.N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of AtherosclerosisElevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.B-type natriuretic peptide-guided therapy for perioperative medicine?BNP molecular forms and processing by the cardiac serine protease corin.Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptidePredictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.Heart failure: furosemide--to DOSE or not to DOSE, that is the questionNT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population.Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.Biochemical markers of aging for longitudinal studies in humans.Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-UpProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study.A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysisPrognostic value of increased carbohydrate antigen in patients with heart failure.B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.Prognostic value of combining echocardiography and natriuretic peptide levels in patients with heart failure.The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population.Hemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure.Biomarker-based risk prediction in the community.Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.Phospholipase C signaling tonically represses basal atrial natriuretic factor secretion from the atria of the heart.Can a cardiac peptide predict mortality in human hypertension?A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics?Natriuretic peptides as markers of cardiovascular risk: the story continues.B-type natriuretic peptide testing in the general population: are we ready for prime time?Natriuretic peptide and cardiovascular risk: is it about "U"?Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study.Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
P2860
Q33653332-02231298-4094-4A9B-A6C2-C7182479F6A0Q33671233-018CD1F1-D647-4E90-8770-747A6AC440D5Q33927398-75612049-9A4D-419A-A34D-0098DD9BCD71Q34014190-000E009B-6583-4A6D-9F6C-7B3BBA2CA4B7Q34075676-C6977DD1-7EC4-41D8-AD84-8F35543FF72AQ34304406-81FCCCD5-C687-49B3-AB66-8B77FFB6D39BQ34369603-BCA5BB41-F1D3-415B-A47B-612C6306974CQ34571982-E70D0C9C-AC82-401C-B9A7-2F0580766F05Q35283673-5276CF06-94F5-404E-9AB2-465270F531F8Q35546884-BDC0D3D1-180A-4458-BEE8-4AE7DA32B9DBQ35586340-9D0192C1-26AA-4E74-BE0F-476E336951BFQ35802753-B6487542-D64B-42DC-BB5D-9A0EF86EC338Q36148695-8159990A-1C01-46FA-96C9-6372E0E8E051Q36155133-212F69AB-2CB6-4377-B39D-D1F509EBACE0Q36281111-78FAA9FB-501D-47DD-A996-43A00AAA0FC4Q36407050-106E1BDF-7FF4-4B53-804E-69F86C6A2E0DQ36433506-AC40D126-467E-4D57-9FC2-562985C4EA27Q36449881-00F3C677-5E1B-4555-9406-F1F10B1A43A3Q36836343-E5E88741-38B5-411F-B318-5173F734893AQ37352819-3B7CD1BB-9022-488D-A8CF-880EF84FE59DQ37505066-62405A59-8C32-4335-9642-EA9675B49379Q37591134-956E1924-431D-4D0B-B637-6477D7F29137Q37612412-7FC3B7A7-8DB8-4292-8171-015B43B2258EQ37722784-F18F9901-54F1-4C06-86B4-CB2DCEE1B4C6Q37833104-7AFA7CDA-1F17-4523-AAFE-E1F321F368E9Q37986680-AA77D28D-93F4-4D70-A249-63E6F18E8C10Q38063118-E7C90034-B018-4413-9FD0-BDB4F85728FCQ38551693-8BA701A7-F640-483E-AA9A-EDE530C13658Q38714511-028D0497-F098-4062-9739-E387AA471D4EQ38757052-D74B0F13-C11D-4CC2-9718-66C05A72DC98Q39215627-A3104046-3D57-4614-BC37-299088CBE4A7Q41140893-E4513F48-4B93-4A22-BB58-BF61F9E17FC2Q42435466-817DD3D6-B47D-4C54-A936-F9D16D41FC64Q42784179-34F60A1A-DB91-44FC-B60B-136DB4D06AD5Q42874933-AFA222C5-D089-4B79-A6AA-413CABEE06CFQ42997221-6EBA6ED4-F460-445D-BB91-7A3972EA471CQ43081292-92EDF351-207C-46FD-BEAC-0E80CFE7ACDFQ43228079-26A6D597-1AC4-45A8-BBEC-28F1591FEE76Q44594551-F2B1B295-DC5B-4771-B655-2A8BAFFEF3D7Q47425600-7C9D0012-1800-4E68-9D7A-F16966D8A771
P2860
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic value of N-term ...... age A/B heart failure subjects
@en
The prognostic value of N-term ...... ge A/B heart failure subjects.
@nl
type
label
The prognostic value of N-term ...... age A/B heart failure subjects
@en
The prognostic value of N-term ...... ge A/B heart failure subjects.
@nl
prefLabel
The prognostic value of N-term ...... age A/B heart failure subjects
@en
The prognostic value of N-term ...... ge A/B heart failure subjects.
@nl
P2093
P2860
P1476
The prognostic value of N-term ...... age A/B heart failure subjects
@en
P2093
Alessandro Cataliotti
Brian D Lahr
Fernando L Martin
John C Burnett
Kent R Bailey
Margaret M Redfield
Paul M McKie
Richard J Rodeheffer
P2860
P304
P356
10.1016/J.JACC.2010.01.031
P407
P577
2010-05-01T00:00:00Z